• Search
  • Advanced Search
Clin Mol Hepatol > Epub ahead of print
Editorial
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
Yewan Park1, Dong Hyun Sinn2
1Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea
2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Correspondence :  Dong Hyun Sinn ,
Tel: +82-2-3410-3409, Fax: +82-2-3410-6983, Email: dh.sinn@samsung.com
Received: July 4, 2024   Accepted: July 7, 2024
KeyWords: Chronic hepatitis B; Tumor; Antiviral drug
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 386 View
  • 40 Download
ORCID iDs

Dong Hyun Sinn
https://orcid.org/0000-0002-7126-5554

Related articles

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study2024 July;30(3)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 604
TOTAL : 2102203
Close layer